The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Innovative approaches for cancer treatment: current perspectives and new challenges
Open accessAbstract
Every year, cancer is responsible for millions of deaths worldwide and, even though much progress has been achieved in medicine, there are still many issues that must be addressed in order to improve cancer therapy.For this reason, oncological research is putting a lot of effort towards finding new and efficient therapies which can alleviate critical side effects caused by conventional treatments.Different technologies are currently under evaluation in clinical trials or have been already introduced into clinical practice.While nanomedicine is contributing to the development of biocompatible materials both for diagnostic and therapeutic purposes, bioengineering of extracellular vesicles and cells derived from patients has allowed designing ad hoc systems and univocal targeting strategies.In this review, we will provide an in-depth analysis of the most innovative advances in basic and applied cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 1×
“In recent years, exosomes detection has been validated as a reliable tool for preclinical practice in different cancer types [64], thanks to the identification of their content: double-stranded DNA (dsDNA) [65, 66], messenger RNA (mRNA), micro RNA (miRNA), long non-coding RNA (lncRNA) [67], proteins and lipids [68].”
MethodDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Doxil, doxorubicin-loaded PEGylated liposomes, were the first nanoparticles approved by the FDA in 1995 to treat AIDS-associated Kaposi’s sarcoma [39].”
BackgroundTumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846 · cited 1×
“This heterogeneity can be appreciated both at spatial and temporal levels and is the key factor responsible for the development of resistant phenotypes promoted by a selective pressure upon treatment administration [1].”
BackgroundThe Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692 · cited 1×
“GPC1-positive exosomes have been employed to detect pancreatic cancer [75], while circulating exosomal macrophage migration inhibitory factor (MIF) was able to predict liver metastasis onset [76].”
Witwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A., Lässer, C., Lötvall, J., Nolte‐‘t Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20360 · Cited by 2,421
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y.-J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., & Lin, J.-K. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,705
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Thakur, B. K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., et al. (2014) · Cell Research · doi:10.1038/cr.2014.44 · Cited by 1,596
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market
Sanchez, C., Belleville, P., Popall, M., & Nicole, L. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00136h · Cited by 1,462
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., et al. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.012 · Cited by 1,410
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230904 · Cited by 1,318
Oxidative stress and cancer: Have we moved forward?
Halliwell, B. (2007) · Biochemical Journal · doi:10.1042/bj20061131 · Cited by 1,302
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Heating the patient: a promising approach?
van der Zee, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf280 · Cited by 1,220
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
Kocaadam, B., & Şanlier, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077195 · Cited by 1,207
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Exosomes: proteomic insights and diagnostic potential
Simpson, R. J., Lim, J. W., Moritz, R. L., & Mathivanan, S. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.17 · Cited by 1,108
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., & Abraham, G. N. (1993) · PubMed · Cited by 1,084
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Kahlert, C., Melo, S. A., Protopopov, A., Tang, J., Seth, S., Koch, M., Zhang, J., Weitz, J., Chin, L., Futreal, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.532267 · Cited by 1,026
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D.-S., Roh, T.-Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,022
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Exosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975
Yu, K.-H., Zhang, C., Berry, G. J., Altman, R. B., Ré, C., Rubin, D. L., & Snyder, M. (2016) · Nature Communications · doi:10.1038/ncomms12474 · Cited by 972
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 968
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Gene therapy clinical trials worldwide to 2017: An update
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3015 · Cited by 903 · cited 1×
“6% of which are related to cancer [158].”
BackgroundThe transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., & Li, G. (2008) · Molecular Therapy · doi:10.1038/mt.2008.1 · Cited by 805
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Cancer active targeting by nanoparticles: a comprehensive review of literature
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1071008 · Cited by 749
Multitargeted cancer prevention by quercetin
Murakami, A., Ashida, H., & Terao, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.046 · Cited by 721
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
Plant-derived anticancer agents: A green anticancer approach
Iqbal, J., Abbasi, B. A., Mahmood, T., Kanwal, S., Ali, B., Shah, S. A., & Khalil, A. T. (2017) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2017.10.016 · Cited by 685
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
McKiernan, J., Donovan, M. J., O’Neill, V., Bentink, S., Noerholm, M., Belzer, S., Skog, J., Kattan, M. W., Partin, A., Andriole, G., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0097 · Cited by 674
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review
Aerts, H. J. W. L. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2631 · Cited by 669
Quantum dots in imaging, drug delivery and sensor applications
Matea, C., Mocan, T., Tabaran, F., Pop, T., Mosteanu, O., Puia, C., Iancu, C., & Mocan, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138624 · Cited by 666
Hydroxyl Free Radical Adduct of Deoxyguanosine: Sensitive Detection and Mechanisms of Formation
Floyd, R. A., Watson, J. J., Wong, P. K., Altmiller, D. H., & Rickard, R. C. (1986) · Free Radical Research Communications · doi:10.3109/10715768609083148 · Cited by 663
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663
Mitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
Brace, C. L. (2009) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2007.10.001 · Cited by 624
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer
Hervault, A., & Thanh, N. T. K. (2014) · Nanoscale · doi:10.1039/c4nr03482a · Cited by 585
Oral bioavailability of curcumin: problems and advancements
Liu, W., Zhai, Y., Heng, X., Che, F. Y., Chen, W., Sun, D., & Zhai, G. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2016.1157883 · Cited by 566
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment
Chikara, S., Nagaprashantha, L. D., Singhal, J., Horne, D., Awasthi, S., & Singhal, S. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.002 · Cited by 559
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · cited 1×
“Angiopep-2 is a peptide that has raised great interest in the treatment of brain cancer [135], because it binds to low-density lipoprotein receptor-related protein-1 (LRP1) of endothelial cells in the BBB, and it is also overexpressed in glioblastoma cancer cells [136].”
BackgroundThe Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 546
Boriachek, K., Islam, M. N., Möller, A., Salomon, C., Nguyen, N., Hossain, M. S. A., Yamauchi, Y., & Shiddiky, M. J. A. (2018) · Small · doi:10.1002/smll.201702153 · Cited by 495
Allenson, K., Castillo, J., San Lucas, F. A., Scelo, G., Kim, D. U., Bernard, V., Davis, G., Kumar, T., Katz, M., Overman, M. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx004 · Cited by 493
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou, A. N., & Papadopoulou, L. C. (2018) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201019666180418095526 · Cited by 480
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances
Xu, S., Olenyuk, B. Z., Okamoto, C. T., & Hamm-Alvarez, S. F. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.041 · Cited by 467
Formation and Intracellular Trafficking of Lipoplexes and Polyplexes
Elouahabi, A., & Ruysschaert, J.-M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.006 · Cited by 462
Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy
Qi, H., Liu, C., Long, L., Ren, Y., Zhang, S., Chang, X., Qian, X., Jia, H., Zhao, J., Sun, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b06939 · Cited by 459
Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318299ac32 · Cited by 452
The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications
Boyer, C., Whittaker, M. R., Bulmus, V., Liu, J., & Davis, T. P. (2010) · NPG Asia Materials · doi:10.1038/asiamat.2010.6 · Cited by 447
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Oxidative Stress and Antioxidants in Disease and Cancer: A Review
Gupta, R. K., Patel, A. K., Shah, N., Choudhary, A. K., Jha, U. K., Yadav, U. C., Gupta, P. K., & Pakuwal, U. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4405 · Cited by 431
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Gutman, D. A., Cooper, L. A. D., Hwang, S. N., Holder, C. A., Gao, J., Aurora, T. D., Dunn, W. D., Scarpace, L., Mikkelsen, T., Jain, R., et al. (2013) · Radiology · doi:10.1148/radiol.13120118 · Cited by 420
Stable drug encapsulation in micelles and microemulsions
NARANG, A., DELMARRE, D., & GAO, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.057 · Cited by 419
Lead Phytochemicals for Anticancer Drug Development
Singh, S., Sharma, B., Kanwar, S. S., & Kumar, A. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01667 · Cited by 411
Muhamad, N., Plengsuriyakarn, T., & Na-Bangchang, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165210 · Cited by 410
Physics of heat generation using magnetic nanoparticles for hyperthermia
Dennis, C. L., & Ivkov, R. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.836758 · Cited by 391
MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT
GIUSTINI, A. J., PETRYK, A. A., CASSIM, S. M., TATE, J. A., BAKER, I., & HOOPES, P. J. (2010) · Nano LIFE · doi:10.1142/s1793984410000067 · Cited by 390
Liu, J., Xiao, Y., & Allen, C. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10533 · Cited by 358 · cited 1×
“For example, solid lipid nanoparticles, made of lipids that are solid at body temperature [44], and fabricated to load hydrophobic drugs [45] have been demonstrated to give a higher drug stability and prolonged release compared to other systems; however, the encapsulation efficiency is often low because of their high…”
BackgroundLiposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Natural products for human health: an historical overview of the drug discovery approaches
Bernardini, S., Tiezzi, A., Laghezza Masci, V., & Ovidi, E. (2018) · Natural Product Research · doi:10.1080/14786419.2017.1356838 · Cited by 355
Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Ni, X., Castanares, M., Mukherjee, A., & Lupold, S. E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189600 · Cited by 349
Biological and therapeutic activities, and anticancer properties of curcumin
PERRONE, D., ARDITO, F., GIANNATEMPO, G., DIOGUARDI, M., TROIANO, G., LO RUSSO, L., DE LILLO, A., LAINO, L., & LO MUZIO, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2749 · Cited by 348
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery
Sun, C.-Y., Shen, S., Xu, C.-F., Li, H.-J., Liu, Y., Cao, Z.-T., Yang, X.-Z., Xia, J.-X., & Wang, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09602 · Cited by 343
Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
Skotland, T., Ekroos, K., Kauhanen, D., Simolin, H., Seierstad, T., Berge, V., Sandvig, K., & Llorente, A. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.011 · Cited by 341
siRNA Conjugate Delivery Systems
Jeong, J. H., Mok, H., Oh, Y.-K., & Park, T. G. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800278e · Cited by 338
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
Mizrak, A., Bolukbasi, M. F., Ozdener, G. B., Brenner, G. J., Madlener, S., Erkan, E. P., Ströbel, T., Breakefield, X. O., & Saydam, O. (2013) · Molecular Therapy · doi:10.1038/mt.2012.161 · Cited by 337
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
Stuchinskaya, T., Moreno, M., Cook, M. J., Edwards, D. R., & Russell, D. A. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05014a · Cited by 329
Gubernator, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566552 · Cited by 325
Suetsugu, A., Honma, K., Saji, S., Moriwaki, H., Ochiya, T., & Hoffman, R. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.007 · Cited by 317
González-Vallinas, M., González-Castejón, M., Rodríguez-Casado, A., & Ramírez de Molina, A. (2013) · Nutrition Reviews · doi:10.1111/nure.12051 · Cited by 302
Liu, T., Zhang, X., Gao, S., Jing, F., Yang, Y., Du, L., Zheng, G., Li, P., Li, C., & Wang, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13465 · Cited by 302
A status report on RNAi therapeutics
Vaishnaw, A. K., Gollob, J., Gamba-Vitalo, C., Hutabarat, R., Sah, D., Meyers, R., de Fougerolles, T., & Maraganore, J. (2010) · Silence · doi:10.1186/1758-907x-1-14 · Cited by 297
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297
Nanomedicine applied to translational oncology: A future perspective on cancer treatment
Bregoli, L., Movia, D., Gavigan-Imedio, J. D., Lysaght, J., Reynolds, J., & Prina-Mello, A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.08.006 · Cited by 296
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Gene silencing by double-stranded RNA
Carthew, R. W. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00204-0 · Cited by 285
Del Re, M., Biasco, E., Crucitta, S., Derosa, L., Rofi, E., Orlandini, C., Miccoli, M., Galli, L., Falcone, A., Jenster, G. W., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.012 · Cited by 284
Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models
Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0154 · Cited by 282
A brief history of gene therapy
Friedmann, T. (1992) · Nature Genetics · doi:10.1038/ng1092-93 · Cited by 273
Computational pathology: Challenges and promises for tissue analysis
Fuchs, T. J., & Buhmann, J. M. (2011) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2011.02.006 · Cited by 265
Grove, O., Berglund, A. E., Schabath, M. B., Aerts, H. J. W. L., Dekker, A., Wang, H., Velazquez, E. R., Lambin, P., Gu, Y., Balagurunathan, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118261 · Cited by 263 · cited 1×
“Radiomics is intended as the high throughput quantification of tumour properties obtained from the analysis of medical images [14, 15, 231].”
BackgroundThermal Tumor Ablation in Clinical Use
Brace, C. (2011) · IEEE Pulse · doi:10.1109/mpul.2011.942603 · Cited by 252
Yang, S., Che, S. P. Y., Kurywchak, P., Tavormina, J. L., Gansmo, L. B., Correa de Sampaio, P., Tachezy, M., Bockhorn, M., Gebauer, F., Haltom, A. R., et al. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1281499 · Cited by 248 · cited 2×
“DsDNA has been detected in exosomes isolated from plasma and serum of different cancer cell types, and mutated genes involved in tumorigenesis, such as mutated KRAS and TP53 [69, 70], have been identified as disease predictors.”
BackgroundTargeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates
Sharkey, R. M., & Goldenberg, D. M. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.4.226 · Cited by 242
Oxidative stress and living cells
Gille, G., & Sigler, K. (1995) · Folia Microbiologica · doi:10.1007/bf02815413 · Cited by 241
Westphal, M., Ylä-Herttuala, S., Martin, J., Warnke, P., Menei, P., Eckland, D., Kinley, J., Kay, R., & Ram, Z. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70274-2 · Cited by 241
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
Cornelio, D. B., Roesler, R., & Schwartsmann, G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm058 · Cited by 234
Hyperthermia-induced drug targeting
May, J. P., & Li, S.-D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.758631 · Cited by 228
Nanostructured carriers as innovative tools for cancer diagnosis and therapy
Martinelli, C., Pucci, C., & Ciofani, G. (2019) · APL Bioengineering · doi:10.1063/1.5079943 · Cited by 228
Self-citationDual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma
Huang, S., Li, J., Han, L., Liu, S., Ma, H., Huang, R., & Jiang, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.064 · Cited by 224
p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study
Ahrendt, S. A., Hu, Y., Buta, M., McDermott, M. P., Benoit, N., Yang, S. C., Wu, L., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.961 · Cited by 222
Delivery systems for siRNA drug development in cancer therapy
Xu, C.-F., & Wang, J. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.011 · Cited by 219
van de Water, F. M., Boerman, O. C., Wouterse, A. C., Peters, J. G. P., Russel, F. G. M., & Masereeuw, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009555 · Cited by 217
Viaud, S., Ploix, S., Lapierre, V., Théry, C., Commere, P.-H., Tramalloni, D., Gorrichon, K., Virault-Rocroy, P., Tursz, T., Lantz, O., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181fe535b · Cited by 201
Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism
Raimondo, S., Saieva, L., Corrado, C., Fontana, S., Flugy, A., Rizzo, A., De Leo, G., & Alessandro, R. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0086-x · Cited by 197
Laser Ablation for Cancer: Past, Present and Future
Schena, E., Saccomandi, P., & Fong, Y. (2017) · Journal of Functional Biomaterials · doi:10.3390/jfb8020019 · Cited by 192
Recht, L., Torres, C. O., Smith, T. W., Raso, V., & Griffin, T. W. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.72.6.0941 · Cited by 185
An influenza virus-inspired polymer system for the timed release of siRNA
Truong, N. P., Gu, W., Prasadam, I., Jia, Z., Crawford, R., Xiao, Y., & Monteiro, M. J. (2013) · Nature Communications · doi:10.1038/ncomms2905 · Cited by 181
Luga, V., & Wrana, J. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1791 · Cited by 179
Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176
Artifacts Associated with the Measurement of Oxidized DNA Bases
Cadet, J., Douki, T., & Ravanat, J. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.105-1470384 · Cited by 176
Novel delivery system for natural products: Nano-curcumin formulations.
Rahimi, H. R., Nedaeinia, R., Shamloo, A. S., Nikdoust, S., & Oskuee, R. K. (2016) · Europe PMC (PubMed Central) · Cited by 176
Recent Advances in Nanoparticle-Mediated siRNA Delivery
Williford, J., Wu, J., Ren, Y., Archang, M. M., Leong, K. W., & Mao, H. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105119 · Cited by 172
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J.-R., Pritchard, L.-L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J.-P., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1019 · Cited by 167
Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Brito, A., Ribeiro, M., Abrantes, A., Pires, A., Teixo, R., Tralhao, J., & Botelho, M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150812145435 · Cited by 163
Exosomes: A new delivery system for tumor antigens in cancer immunotherapy
Cho, J., Yeo, D., Son, H., Kim, H., Jung, D., Ko, J., Koh, J. S., Kim, Y., & Kim, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.20757 · Cited by 160
Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
Gray, M. J., Van Buren, G., Dallas, N. A., Xia, L., Wang, X., Yang, A. D., Somcio, R. J., Lin, Y. G., Lim, S., Fan, F., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm279 · Cited by 158
A Review on Preparation, Properties and Applications of Polymeric Nanoparticle-Based Materials
Nasir, A., Kausar, A., & Younus, A. (2014) · Polymer-Plastics Technology and Engineering · doi:10.1080/03602559.2014.958780 · Cited by 157
Al‐Jamal, K. T., Al-Jamal, W. T., Wang, J. T.-W., Rubio, N., Buddle, J. C., Gathercole, D., Zloh, M., & Kostarelos, K. (2013) · ACS Nano · doi:10.1021/nn305860k · Cited by 154
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging
Gao, J., Chen, K., Miao, Z., Ren, G., Chen, X. S., Gambhir, S. S., & Cheng, Z. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.053 · Cited by 143
RNA interference therapeutics for cancer: Challenges and opportunities (Review)
Bora, R. S., Gupta, D., Mukkur, T. K. S., & Saini, K. S. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.871 · Cited by 141
Pillé, J.-Y., Li, H., Blot, E., Bertrand, J., Pritchard, L. L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J., Soria, J., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-248 · Cited by 140
Berberine as a potential autophagy modulator
Mohammadinejad, R., Ahmadi, Z., Tavakol, S., & Ashrafizadeh, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28325 · Cited by 132
Effects of quercetin on proliferation and migration of human glioblastoma U251 cells
Liu, Y., Tang, Z., Lin, Y., Qu, X., Lv, W., Wang, G., & Li, C.-L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.044 · Cited by 130
Kumar, G., Mittal, S., Sak, K., & Tuli, H. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.022 · Cited by 126
Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications
Räty, J. K., Pikkarainen, J. T., Wirth, T. C., & Ylä‐Herttuala, S. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801010013 · Cited by 118
Grillone, A. F., Riva, E. R., Mondini, A., Forte, C., Calucci, L., Innocenti, C., Fernández, C. D. J., Cappello, V., Gemmi, M., Moscato, S., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500235 · Cited by 115
Self-citationKong, J., Cooper, L., Wang, F., Gao, J., Teodoro, G., Scarpace, L. M., Mikkelsen, T., Schniederjan, M., Moreno, C. S., Saltz, J. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081049 · Cited by 115
Antisense RNA gene therapy for studying and modulating biological processes
Weiss, B., Davidkova, G., & Zhou, L.-W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050296 · Cited by 113
Romo‐Bucheli, D., Janowczyk, A. R., Gilmore, H. L., Romero, E., & Madabhushi, A. (2016) · Scientific Reports · doi:10.1038/srep32706 · Cited by 108
Yang, F., SONG, L., Wang, H., Wang, J., Xu, Q., & Xing, N. (2015) · Oncology Reports · doi:10.3892/or.2015.3886 · Cited by 101
Cucurmin, anticancer, & antitumor perspectives: A comprehensive review
Imran, M., Ullah, A., Saeed, F., Nadeem, M., Arshad, M. U., & Suleria, H. A. R. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1252711 · Cited by 101
Lynam‐Lennon, N., Maher, S. G., Maguire, A. A., Phelan, J. J., Muldoon, C. B., Reynolds, J. V., & O'Sullivan, J. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100738 · Cited by 100
Kenny, G. D., Kamaly, N., Kalber, T. L., Brody, L., Sahuri-Arisoylu, M., Shamsaei, E., Miller, A. D., & Bell, J. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.020 · Cited by 100
TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Griffith, T. S., Stokes, B., Kucaba, T. A., Earel, J. K., VanOosten, R. L., Brincks, E. L., & Norian, L. A. (2009) · Current Gene Therapy · doi:10.2174/156652309787354612 · Cited by 99
Tapeinos, C., Marino, A., Battaglini, M., Migliorin, S., Brescia, R., Scarpellini, A., Fernández, C. D. J., Prato, M., Drago, F., & Ciofani, G. (2018) · Nanoscale · doi:10.1039/c8nr05520c · Cited by 99
Self-citationIntegrated morphologic analysis for the identification and characterization of disease subtypes
Cooper, L., Kong, J., Gutman, D. A., Wang, F., Gao, J., Appin, C., Cholleti, S. R., Pan, T. C., Sharma, A., Scarpace, L. M., et al. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000700 · Cited by 94
WITHDRAWN: Gene silencing by double-stranded RNA
Fire, A. Z. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402253 · Cited by 94
Chemistry and formulations for siRNA therapeutics
Gallas, A., Alexander, C., Davies, M. C., Puri, S., & Allen, S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35520a · Cited by 93
Kalpathy–Cramer, J., Freymann, J., Kirby, J., Kinahan, P. E., & Prior, F. (2014) · Translational Oncology · doi:10.1593/tlo.13862 · Cited by 92
Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells.
Sordillo, P. P., & Helson, L. (2015) · PubMed · Cited by 88
Lewis, J. S., Ali, S., Luo, J. R., Thorstad, W. L., & Madabhushi, A. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000086 · Cited by 86
Cancer gene therapy targeting cellular apoptosis machinery
Jia, L., Chen, S., & Yang, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.008 · Cited by 84
Rapid Advances in Immunotherapy to Treat Cancer
McCune, J. S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.985 · Cited by 84
Exosome-mediated microenvironment dysregulation in leukemia
Kumar, B., García, M., Murakami, J. L., & Chen, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.017 · Cited by 82
Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary
Markman, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.11.1469 · Cited by 82
Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7
Lebedeva, I. V., Su, Z.-Z., Sarkar, D., & Fisher, P. B. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00134-7 · Cited by 81
Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel
Kulhari, H., Pooja, D., Shrivastava, S., Naidu, V. G. M., & Sistla, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.026 · Cited by 78
Zhou, J., Wu, Y., Wang, C., Cheng, Q., Han, S., Wang, X., Zhang, J., Deng, L., Zhao, D., Du, L., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02915 · Cited by 78
Martina, M.-S., Nicolas, V., Wilhelm, C., Ménager, C., BARRATT, G. M., & Lesieur, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.025 · Cited by 75
Imaging-guided high-efficient photoacoustic tumor therapy with targeting gold nanorods
Zhong, J., Wen, L., Yang, S., Xiang, L., Chen, Q., & Xing, D. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.04.002 · Cited by 75
Wei, T., Zhang, J., Zeng, X., Liu, D. X., Liu, G., Zhu, X., Liu, Y., Yu, Q., Huang, L., & Mei, L. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400751 · Cited by 74
Magnetic resonance imaging of atherosclerosis
Leiner, T., Gerretsen, S. C., Botnar, R. M., Lutgens, E., Cappendijk, V. C., Kooi, M. E., & van Engelshoven, J. M. A. (2005) · European Radiology · doi:10.1007/s00330-005-2646-8 · Cited by 71
Farooqı, A. A., Qureshi, M. Z., Khalid, S., Attar, R., Martinelli, C., Sabitaliyevich, U. Y., Nurmurzayevich, S. B., Taverna, S., Poltronieri, P., & Xu, B. (2019) · Cancers · doi:10.3390/cancers11040478 · Cited by 68
Self-citationSynthetic cell surface receptors for delivery of therapeutics and probes
Hymel, D., & Peterson, B. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.007 · Cited by 67
Therapeutic Nanoparticles for Targeted Delivery of Anticancer Drugs
Alasvand, N., Urbanska, A. M., Rahmati, M., Saeidifar, M., Gungor‐Ozkerim, P. S., Sefat, F., Rajadas, J., & Mozafari, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00013-7 · Cited by 66
Foran, D. J., Yang, L., Chen, W., Hu, J., Goodell, L. A., Reiss, M., Wang, F., Kurc, T., Pan, T., Sharma, A., et al. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000170 · Cited by 65
Whelan, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03547-6 · Cited by 64
Kim, H. S., Song, I. H., Kim, J. C., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.003 · Cited by 62
Anti-Genes: siRNA, Ribozymes and Antisense
Scanlon, K. J. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376689 · Cited by 61
Andreozzi, P., Diamanti, E., Py-Daniel, K. R., Cáceres‐Vélez, P. R., Martinelli, C., Πολιτάκος, Ν., Escobar, A., Muzi-Falconi, M., Azevedo, R. B., & Moya, S. E. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11132 · Cited by 53
Self-citationSchlett, C. L., Hendel, T., Weckbach, S., Reiser, M. F., Kauczor, H., Nikolaou, K., Günther, M., Forsting, M., Hosten, N., Völzke, H., et al. (2016) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0042-104510 · Cited by 51
ElBayoumi, T. A., Shen, R., Kim, J., & Yao, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s103332 · Cited by 47
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Metadata
- Authors
- Pucci, C., Martinelli, C., & Ciofani, G.
- Venue
- ecancermedicalscience
- Publisher
- Ecancer Global Foundation
- Published
- 2019-09-10
- Volume
- 13
- Pages
- 961-961
- ISSN
- 1754-6605 (ISSN-L)
- OpenAlex
- W2972713173
- Cited by
- 814
- References
- 211
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.